Guard Therapeutics International AB (GUARD) — Cash Flow Reinvestment Rate
Latest as of March 2015:
2.37x
Guard Therapeutics International AB (GUARD) has a Cash Flow Reinvestment Rate of 2.37x as of March 2015, reinvesting Skr2.75 Million (capex Skr2.75 Million ) from operating cash flow of Skr1.16 Million. Explore GUARD operating cash flow to assess how effectively this company generates cash.
Reinvestment Rate
2.37x
(Capex + Investments) / Operating CF
Total Reinvested
Skr2.75 Million
Capex + Investments
Operating Cash Flow
Skr1.16 Million
SEK
Capital Expenditures
Skr2.75 Million
SEK
Annual Cash Flow Reinvestment Rate for Guard Therapeutics International AB (None–None)
Year-by-year capital reinvestment analysis for Guard Therapeutics International AB. For live market cap and broader valuation context, see Guard Therapeutics International AB (GUARD) total market value.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow